<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>47</viewCount><searchCount>0</searchCount></scores><additional><submitter>Borsari C</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><pagination>1908-1928</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7997565</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>63(5)</volume><pubmed_abstract>After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component that targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This Perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In detail, we discuss chemical features of chimeric molecules and their use for targeted delivery and for target engagement studies.</pubmed_abstract><journal>Journal of medicinal chemistry</journal><pubmed_title>Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology.</pubmed_title><pmcid>PMC7997565</pmcid><funding_grant_id>AIRC IG16977</funding_grant_id><pubmed_authors>Costi MP</pubmed_authors><pubmed_authors>Tait A</pubmed_authors><pubmed_authors>Trader DJ</pubmed_authors><pubmed_authors>Borsari C</pubmed_authors><view_count>47</view_count></additional><is_claimable>false</is_claimable><name>Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology.</name><description>After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component that targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This Perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In detail, we discuss chemical features of chimeric molecules and their use for targeted delivery and for target engagement studies.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Mar</publication><modification>2024-11-20T17:50:45.492Z</modification><creation>2022-02-09T10:18:04.825Z</creation></dates><accession>S-EPMC7997565</accession><cross_references><pubmed>32023055</pubmed><doi>10.1021/acs.jmedchem.9b01456</doi></cross_references></HashMap>